Resolution 54/6. Promoting adequate availability of internationally controlled narcotic drugs and psychotropic substances for medical and scientific purposes while preventing their diversion and abuse

1. Requests the United Nations Office on Drugs and Crime, in consultation with the International Narcotics Control Board and the World Health Organization, to review and, where necessary, to update its model laws to ensure that they reflect an appropriate balance between ensuring adequate access to internationally controlled drugs and preventing their diversion and abuse, in line with the provisions of the international drug control conventions;

4. Requests the United Nations Office on Drugs and Crime and the International Narcotics Control Board to continue their efforts to ensure the adequate availability of internationally controlled drugs for medical and scientific purposes worldwide, cooperating as appropriate, through the Access to Controlled Medications Programme of the World Health Organization, while continuing their activities to prevent diversion and abuse;

8. Reiterates its call upon Member States to fulfil in a timely manner their reporting obligations to the International Narcotics Control Board and the Secretary-General, as appropriate, concerning the use in their countries of internationally controlled narcotic drugs and psychotropic substances for medical and scientific purposes and the diversion of, trafficking in and abuse of those drugs and substances, as required under the international drug control conventions;

9. Encourages Member States to report to the International Narcotics Control Board data on the consumption of psychotropic substances for medical and scientific purposes in the same manner as for narcotic drugs, in order to enable the Board to analyse levels of consumption of psychotropic substances in an accurate manner and to promote their adequate availability;

10. Also encourages Member States to ensure the involvement and coordinated action of their relevant bodies and agencies responsible, inter alia, for health care, justice, drug regulation and law enforcement, with a view to defining, updating and achieving, through their respective national laws, policies and programmes, an appropriate balance between access to and availability of internationally controlled drugs for medical and scientific purposes and the prevention of their diversion and abuse;

11. Invites Member States, the United Nations Office on Drugs and Crime and relevant international organizations to facilitate the provision of technical assistance to developing countries, in particular developing countries seeking to improve the availability of internationally controlled drugs for medical and scientific purposes while preventing their diversion and abuse, including, where appropriate, through support for South-South cooperation